Karyopherin α-2 Mediates MDC1 Nuclear Import through a Functional Nuclear Localization Signal in the tBRCT Domain of MDC1.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
10 Apr 2020
Historique:
received: 19 03 2020
revised: 06 04 2020
accepted: 08 04 2020
entrez: 16 4 2020
pubmed: 16 4 2020
medline: 7 1 2021
Statut: epublish

Résumé

Mediator of DNA damage checkpoint protein 1 (MDC1) plays a vital role in DNA damage response (DDR) by coordinating the repair of double strand breaks (DSBs). Here, we identified a novel interaction between MDC1 and karyopherin α-2 (KPNA2), a nucleocytoplasmic transport adaptor, and showed that KPNA2 is necessary for MDC1 nuclear import. Thereafter, we identified a functional nuclear localization signal (NLS) between amino acid residues 1989-1994 of the two Breast Cancer 1 (BRCA1) carboxyl-terminal (tBRCT) domain of MDC1 and demonstrated disruption of this NLS impaired interaction between MDC1 and KPNA2 and reduced nuclear localization of MDC1. In KPNA2-depleted cells, the recruitment of MDC1, along with the downstream signaling p roteins Ring Finger Protein 8 (RNF8), 53BP1-binding protein 1 (53BP1), BRCA1, and Ring Finger Protein 168 (RNF168), to DNA damage sites was abolished. Additionally, KPNA2-depleted cells had a decreased rate of homologous recombination (HR) repair. Our data suggest that KPNA2-mediated MDC1 nuclear import is important for DDR signaling and DSB repair.

Identifiants

pubmed: 32290222
pii: ijms21072650
doi: 10.3390/ijms21072650
pmc: PMC7177644
pii:
doi:

Substances chimiques

Adaptor Proteins, Signal Transducing 0
Cell Cycle Proteins 0
MDC1 protein, human 0
Nuclear Localization Signals 0
alpha Karyopherins 0
karyopherin alpha 2 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : National Research Foundation of Korea
ID : NRF-2015R1A5A2009070
Organisme : National Research Foundation of Korea
ID : NRF-2017R1A2B2008064
Organisme : National Research Foundation of Korea
ID : NRF-2020R1A2C2003423

Références

Nature. 2003 Feb 27;421(6926):952-6
pubmed: 12607003
Front Genet. 2014 Jun 11;5:175
pubmed: 24966870
Cell Signal. 2014 May;26(5):857-67
pubmed: 24440306
Cell. 1994 Dec 2;79(5):767-78
pubmed: 8001116
Nucleus. 2010 Mar-Apr;1(2):166-78
pubmed: 21326949
Nature. 2003 Feb 27;421(6926):961-6
pubmed: 12607005
J Biol Chem. 2005 Nov 25;280(47):39594-600
pubmed: 16188882
J Mol Biol. 2016 May 22;428(10 Pt A):2060-90
pubmed: 26523678
Nat Struct Mol Biol. 2005 Oct;12(10):902-9
pubmed: 16186822
EMBO J. 1996 Apr 15;15(8):1810-7
pubmed: 8617226
Mol Carcinog. 2006 Jun;45(6):403-8
pubmed: 16691596
EMBO J. 2004 Jul 7;23(13):2674-83
pubmed: 15201865
J Biol Chem. 2005 Mar 11;280(10):8855-61
pubmed: 15632137
Chromosoma. 2010 Aug;119(4):337-49
pubmed: 20224865
Nat Commun. 2017 Oct 12;8(1):903
pubmed: 29026069
J Biol Chem. 2003 Oct 24;278(43):42346-51
pubmed: 12909615
Biochim Biophys Acta. 2011 Sep;1813(9):1562-77
pubmed: 20977914
DNA Repair (Amst). 2004 Aug-Sep;3(8-9):953-7
pubmed: 15279781
DNA Repair (Amst). 2010 Dec 10;9(12):1264-72
pubmed: 20971042
Cell. 1995 Dec 1;83(5):683-92
pubmed: 8521485
Trends Cell Biol. 2004 Sep;14(9):505-14
pubmed: 15350979
Cell Death Differ. 2012 May;19(5):798-807
pubmed: 22075984
Cell. 2005 Dec 29;123(7):1213-26
pubmed: 16377563
Nature. 1999 May 20;399(6733):221-9
pubmed: 10353244
Mol Cell Biol. 2006 Dec;26(23):8697-709
pubmed: 17000757
Curr Opin Struct Biol. 2001 Dec;11(6):703-15
pubmed: 11751052
Nature. 2003 Feb 27;421(6926):957-61
pubmed: 12607004
Proc Natl Acad Sci U S A. 2008 Aug 12;105(32):11200-5
pubmed: 18678890
BMC Bioinformatics. 2009 Jun 29;10:202
pubmed: 19563654
Biochem J. 2015 Feb 15;466(1):13-28
pubmed: 25656054
J Biol Chem. 2010 Oct 22;285(43):33113-22
pubmed: 20699224
Mol Cell. 2006 Jan 20;21(2):187-200
pubmed: 16427009
BMC Cell Biol. 2010 Aug 11;11:63
pubmed: 20701745

Auteurs

Kamalakannan Radhakrishnan (K)

Laboratory of Genomic Instability and Cancer therapeutics, Cancer Mutation Research Center, Chosun University, Gwangju 61452, Korea.

Seon-Joo Park (SJ)

Laboratory of Genomic Instability and Cancer therapeutics, Cancer Mutation Research Center, Chosun University, Gwangju 61452, Korea.
Department of Premedical Sciences, College of Medicine, Chosun University, Gwangju 61452, Korea.

Seok Won Kim (SW)

Laboratory of Genomic Instability and Cancer therapeutics, Cancer Mutation Research Center, Chosun University, Gwangju 61452, Korea.
Department of Neurosurgery, College of Medicine, Chosun University, Gwangju 61452, Korea.

Gurusamy Hariharasudhan (G)

Laboratory of Genomic Instability and Cancer therapeutics, Cancer Mutation Research Center, Chosun University, Gwangju 61452, Korea.

Seo-Yeon Jeong (SY)

Laboratory of Genomic Instability and Cancer therapeutics, Cancer Mutation Research Center, Chosun University, Gwangju 61452, Korea.
Department of Cellular and Molecular Medicine, College of Medicine, Chosun University, Gwangju 61452, Korea.

In Youb Chang (IY)

Department of Anatomy, College of Medicine, Chosun University, Gwangju 61452, Korea.

Jung-Hee Lee (JH)

Laboratory of Genomic Instability and Cancer therapeutics, Cancer Mutation Research Center, Chosun University, Gwangju 61452, Korea.
Department of Cellular and Molecular Medicine, College of Medicine, Chosun University, Gwangju 61452, Korea.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH